Two doses of the Pfizer Inc and BioNTech COVID-19 vaccine was protective against severe disease in children aged 5 to 11 during the recent omicron variant surge, but quickly lost…

Read more »

The post Study: Pfizer/BioNTech COVID Vaccine Less Effective in Ages 5-11 appeared first on Hamodia.

In related news:

  1. When Will the Toilet Paper Shortage End?
  2. Pandemic Forces U.S. Supreme Court to Hear Cases in a New Way
  3. U.S. Finds First Case of Coronavirus in Wild Animal, a Utah Mink
  4. Congressional Leaders Report Progress in Talks for Fresh COVID-19 Aid
  5. ‘A Whirlwind’: 1st Ohio Vaccine Lottery Winners Speak Out